Association between betamethasone levels and respiratory distress syndrome in preterm births: A prospective cohort study. Issue 10 (9th August 2022)
- Record Type:
- Journal Article
- Title:
- Association between betamethasone levels and respiratory distress syndrome in preterm births: A prospective cohort study. Issue 10 (9th August 2022)
- Main Title:
- Association between betamethasone levels and respiratory distress syndrome in preterm births: A prospective cohort study
- Authors:
- Zafran, Noah
Massalha, Manal
Suleiman, Abeer
Massalha, Refaat
Mahagna, Lila
Weiner, Scott A.
Romano, Shabtai
Shalev, Eliezer
Salim, Raed - Abstract:
- Abstract: The recommended fixed dosage of betamethasone for pregnancies at risk of preterm birth was determined in the 1970s, regardless of gestational age (GA), number of fetuses, and maternal weight. We aimed to examine the association between maternal and neonatal betamethasone serum levels and neonatal respiratory distress syndrome (RDS) and to examine whether levels correlate with maternal weight, GA, or number of fetuses. A prospective study was conducted at a single academic medical center between August 2016 and February 2019. Women received betamethasone and delivered between 28 +0 and 34 +6 weeks were included. Maternal serum levels (MSLs), and neonatal serum levels (NSLs) of betamethasone at delivery were analyzed using Corticosteroid enzyme‐linked immunosorbent assay kit. RDS was diagnosed according to clinical and radiographic findings. We assumed that the sensitivity of NSLs to detect RDS is 95%; hence, 150 neonates were needed (power 80%, alpha 0.05). Overall, 124 women were included; including 96 (77.4%) singletons, 26 (21.0%) twins, and 2 (1.6%) triplets, corresponding to 154 neonates. RDS was diagnosed in 35 neonates (22.7%). After adjusting for GA, time elapsed from the last dose, and number of doses, NSLs were associated with RDS (relative risk: 0.97, 95% confidence interval: 0.94–0.99, p = 0.011). A level of 6.00 ng/ml predicted RDS with a sensitivity of 80.0% and specificity of 64.7%. Adjusted MSLs were not associated with RDS. Both maternal andAbstract: The recommended fixed dosage of betamethasone for pregnancies at risk of preterm birth was determined in the 1970s, regardless of gestational age (GA), number of fetuses, and maternal weight. We aimed to examine the association between maternal and neonatal betamethasone serum levels and neonatal respiratory distress syndrome (RDS) and to examine whether levels correlate with maternal weight, GA, or number of fetuses. A prospective study was conducted at a single academic medical center between August 2016 and February 2019. Women received betamethasone and delivered between 28 +0 and 34 +6 weeks were included. Maternal serum levels (MSLs), and neonatal serum levels (NSLs) of betamethasone at delivery were analyzed using Corticosteroid enzyme‐linked immunosorbent assay kit. RDS was diagnosed according to clinical and radiographic findings. We assumed that the sensitivity of NSLs to detect RDS is 95%; hence, 150 neonates were needed (power 80%, alpha 0.05). Overall, 124 women were included; including 96 (77.4%) singletons, 26 (21.0%) twins, and 2 (1.6%) triplets, corresponding to 154 neonates. RDS was diagnosed in 35 neonates (22.7%). After adjusting for GA, time elapsed from the last dose, and number of doses, NSLs were associated with RDS (relative risk: 0.97, 95% confidence interval: 0.94–0.99, p = 0.011). A level of 6.00 ng/ml predicted RDS with a sensitivity of 80.0% and specificity of 64.7%. Adjusted MSLs were not associated with RDS. Both maternal and neonatal serum levels were not associated with the number of fetuses and maternal weight. In conclusion, NSLs are associated with RDS whereas MSLs are not. … (more)
- Is Part Of:
- Clinical and translational science. Volume 15:Issue 10(2022)
- Journal:
- Clinical and translational science
- Issue:
- Volume 15:Issue 10(2022)
- Issue Display:
- Volume 15, Issue 10 (2022)
- Year:
- 2022
- Volume:
- 15
- Issue:
- 10
- Issue Sort Value:
- 2022-0015-0010-0000
- Page Start:
- 2528
- Page End:
- 2537
- Publication Date:
- 2022-08-09
- Subjects:
- Medicine, Experimental -- Periodicals
Medical innovations -- Periodicals
616.027 - Journal URLs:
- http://www3.interscience.wiley.com/journal/118902557/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cts.13382 ↗
- Languages:
- English
- ISSNs:
- 1752-8054
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.255400
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24812.xml